You are here
ESSCB Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras
On November 14, 2011, the ESSCB Funding Committee voted to adopt a Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras, which was developed and...
New Model Informed Consent Forms
ESSCB Model Informed Consent Forms On November 14, 2011, the ESSCB Funding Committee approved five model informed consent forms developed by the ESSCB Ethics Committee. The forms provide guidance...
Vitamin C May Help Treat Certain Blood Cancers
Research from Iannis Aifantis and colleagues at NYU School of Medicine finds vitamin C may work as a therapy for some leukemias and myelodysplastic syndromes by activating TET2.
NYSTEM Consortium Creates Spinoff Company
A NYSTEM funded consortium based at Roswell Park Cancer Institute launched a new biotechnology company to target cancer
Parkin mutations cause changes in electrophysiological properties of neurons
Jian Feng’s group identifies a pathophysiological change in neurons derived from Parkinson’s patients harboring parkin mutations
NYSTEM Awardee Launches Biotech Company
Regenerative medicine company receives venture capital funding for Parkinson’s research
Patient Cells Shed Light On Developmental Mechanisms Underlying Schizophrenia
A new research collaboration from scientists at the University at Buffalo and the Icahn School of Medicine at Mount Sinai identifies a role for Integrative Nuclear FGFR1 Signaling in schizophrenia
Toward Personalizing Treatments of Gliomas
Testing TGF-β inhibition as a radiosensitizer in tumor explants points toward a future of personalized therapies
A Developmental Program for Cell Cannibalism
Research from Jeremy Nance identifies cell cannibalism during development of C. elegans
Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumors into Chemoresistant Cancer Stem Cells
Vascular niche of tumor-associated vascular endothelial cells (TECs) can enable cancer stem cell aggressiveness.
NYSTEM Releases Second Strategic Plan
ESSCB releases second Strategic Plan reviewing NYSTEM's accomplishments and setting forth objectives for the next phase of the program: "The New York State Stem Cell Science (NYSTEM) Program: A Report on Progress and a Vision for the Future."
International Collaboration Produces Haploid Human Embryonic Stem Cells
An international collaboration between researchers in New York and Israel produces haploid human embryonic stem cells capable of normal differentiation.